PD64-08 CAN WE AVOID BLADDER AUGMENTATION IN CASE OF FAILURE OF A FIRST INTRADETRUSOR BOTULINUM TOXIN INJECTIONS IN PATIENTS WITH SPINAL DYSRAPHISM?

Authors :: P. Grise
Emmanuel Chartier-Kastler
Alix Verrando
M. de Sèze
Alexia Even
Xavier Biardeau
Christian Saussine
Jacques Kerdraon
C. Maurin
Juliette Hascoet
P. Denys
Grégoire Capon
Brigitte Schurch
Gilles Karsenty
Evelyne Castel-Lacanal
J.-M. Boutin
Jean-Nicolas Cornu
B. Peyronnet
C. Lenormand
L. Monleon
Maximilien Baron
Andrea Manunta
G. Amarenco
C. Allenet
Loic Lenormand
P. Mouracade
X. Gamé
M.A. Perrouin-Verbe
François Marcelli
Source :: Journal of Urology. 197
Publication Year :: 2017
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2017.

Subjects :: medicine.medical_specialty
Bladder augmentation
business.industry
Spinal dysraphism
Urology
Anesthesia
medicine
In patient
business
Botulinum toxin
Surgery
medicine.drug

Full Text Access

Tools